Chronic administration of BMS309403 improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells |
| |
Authors: | Lee Mary Yk Li Huiying Xiao Yang Zhou Zhiguang Xu Aimin Vanhoutte Paul M |
| |
Affiliation: | 1Department of Pharmacology & Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China;2Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China;3Diabetes Center, Metabolic Syndrome Research Center, Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University, Changsha, China |
| |
Abstract: | ![]()
BACKGROUND AND PURPOSEAdipocyte fatty acid-binding protein (A-FABP) is up-regulated in regenerated endothelial cells and modulates inflammatory responses in macrophages. Endothelial dysfunction accompanying regeneration is accelerated by hyperlipidaemia. Here, we investigate the contribution of A-FABP to the pathogenesis of endothelial dysfunction in the aorta of apolipoprotein E-deficient (ApoE−/−) mice and in cultured human endothelial cells.EXPERIMENTAL APPROACHA-FABP was measured in aortae of ApoE−/−mice and human endothelial cells by RT-PCR, immunostaining and immunoblotting. Total and phosphorylated forms of endothelial nitric oxide synthase (eNOS) were measured by immunoblotting. Changes in isometric tension were measured in rings of mice aortaeKEY RESULTSA-FABP was expressed in aortic endothelium of ApoE−/− mice aged 12 weeks and older, but not at 8 weeks or in C57 wild-type mice. Reduced endothelium-dependent relaxations to acetylcholine, UK14304 (selective α2-adrenoceptor agonist) and {"type":"entrez-nucleotide","attrs":{"text":"A23187","term_id":"833253","term_text":"A23187"}}A23187 (calcium ionophore) and decreased protein presence of phosphorylated and total eNOS were observed in aortae of 18 week-old ApoE−/− mice compared with age-matched controls. A 6 week treatment with the A-FABP inhibitor, BMS309403, started in 12 week-old mice, improved endothelial function, phosphorylated and total eNOS and reduced plasma triglyceride levels but did not affect endothelium-independent relaxations. The beneficial effect of BMS309403 on UK14304-induced relaxations was attenuated by Pertussis toxin. In cultured human microvascular endothelial cells, lipid-induced A-FABP expression was associated with reduced phosphorylated eNOS and NO production and was reversed by BMS309403.CONCLUSIONS AND IMPLICATIONSElevated expression of A-FABP in endothelial cells contributes to their dysfunction both in vivo and in vitro. |
| |
Keywords: | A-FABP endothelium-dependent relaxation eNOS endothelial dysfunction nitric oxide atherosclerosis |
本文献已被 PubMed 等数据库收录! |
|